Cite
Hagras M, Saleh MA, Ezz Eldin RR, et al. 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and . J Enzyme Inhib Med Chem. 2022;37(1):380-396doi: 10.1080/14756366.2021.2015342.
Hagras, M., Saleh, M. A., Ezz Eldin, R. R., Abuelkhir, A. A., Khidr, E. G., El-Husseiny, A. A., El-Mahdy, H. A., Elkaeed, E. B., & Eissa, I. H. (2022). 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and . Journal of enzyme inhibition and medicinal chemistry, 37(1), 380-396. https://doi.org/10.1080/14756366.2021.2015342
Hagras, Mohamed, et al. "1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and ." Journal of enzyme inhibition and medicinal chemistry vol. 37,1 (2022): 380-396. doi: https://doi.org/10.1080/14756366.2021.2015342
Hagras M, Saleh MA, Ezz Eldin RR, Abuelkhir AA, Khidr EG, El-Husseiny AA, El-Mahdy HA, Elkaeed EB, Eissa IH. 1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and . J Enzyme Inhib Med Chem. 2022 Dec;37(1):380-396. doi: 10.1080/14756366.2021.2015342. PMID: 34923885.
Copy
Download .nbib